Ads
related to: keytruda cancer drug- Dosing & Administration
Learn About The ENHERTU Regimen
& Access The Patient Brochure.
- See Clinical Guidelines
Is ENHERTU An Option For Your
Patients? View Clinical Guidelines.
- Official Physician Site
See If ENHERTU Is An Option &
Access Resources For Your Practice.
- ENHERTU Access & Support
Learn About A Support Program &
Find Downloadable Resources.
- MOA Info For ENHERTU
Healthcare Professionals: Visit
Site To See How ENHERTU Works.
- Register For Updates
Request A Representative & Sign Up
For Updates To Learn Abut ENHERTU
- Dosing & Administration
Search results
BMS secures another EC approval for Opdivo combination
Pharmaceutical Technology via Yahoo Finance· 17 hours agoThe decision follows a US Food and Drug Administration (FDA) approval for the Opdivo combination...
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 3 days agoPembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the market. A...
Merck to Buy Eye Drug Company Eyebiotech for Up to $3 Billion. It’s Doubling Down on Deals.
Barrons.com· 17 hours agoThe pharmaceutical company agrees to buy eye drug company Eyebiotech for up to $3 billion as it...
Merck Nears $1.3 Billion Cash Deal for Eye-Drug Company EyeBio, WSJ Reports
US News & World Report· 1 day agoMerck did not immediately respond to Reuters' request for a comment, while Eyebiotech declined to comment. Eyebiotech is a clinical stage opthalmology company, with operations in the U.S. and ...
Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports
Reuters via Yahoo Finance· 1 day agoMerck has said it's in the market for deals of up to around $15 billion as it plans ways to deal...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 7 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
Merck to pay as much as $3 billion for eye treatment startup
Crain's New York Business· 16 hours agoWhile it raised its profit and sales forecast for the year on Keytruda sales, Merck has been on the...
Merck to acquire eye drug company EyeBio for up to $3 billion
WSAU Wausau· 19 hours ago(Reuters) - Merck said on Wednesday it would acquire eye diseasedrug developer EyeBio for up to $3...
TILT Biotherapeutics reports data from Phase I trial of ovarian cancer treatment
Clinical Trials Arena via Yahoo Finance· 2 days agoTILT-123 is an oncolytic adenovirus featuring tumour necrosis factor alpha (TNFα) and interleukin-2...
Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?
Benzinga via Yahoo Finance· 5 days agoKeytruda (pembrolizumab) is Merck & Co Inc’s (NYSE:MRK) top selling cancer drug. The abstract...
Ads
related to: keytruda cancer drug